MMA Board Selects 6 Priorities for Upcoming Legislative Session
November 19, 2026
At its November 14 meeting in St. Paul, the MMA's Board of Trustees selected six priorities for the upcoming legislative session, which begins January 12, 2027.
November 19, 2026
Minnesota has been chosen as one of seven states to participate in a study on newborn screening programs over the next couple of years.
BRIDGES-NBS is a feasibility NIH-funded study assessing the addition of optional newborn genomic sequencing-based screening. In addition to standard newborn screening (NBS), babies in the study will have genomic sequencing looking for genetic changes associated with 777 medically actionable health conditions.
Joining the study is a choice. A baby’s parent (legal guardian) must provide signed consent shortly after birth for a baby to participate.
Abnormal (positive) BRIDGES-NBS results will be called to the baby’s primary care provider by genetic counselors at the Minnesota Newborn Screening Program. Recommended next steps will be discussed. The follow-up protocol after a positive BRIDGES-NBS result is being planned in Minnesota, and will be shared once finalized.
Newborn genomic screening through BRIDGES-NBS is not comprehensive genetic testing. Even if an infant has normal BRIDGES-NBS screening results, providers should still complete their typical evaluations, referrals (e.g. to Genetics), and testing for clinical concerns.
More information is available on the Minnesota Department of Health (MDH) Newborn Screening Program’s BRIDGES-NBS webpage, including details about the study process, eligibility, conditions selected, and resources. The webpage will be updated periodically as more information becomes available. The BRIDGES-NBS study website also has more information about the study, including privacy protections and future implications (FAQ page).
The Minnesota Newborn Screening Program genetic counselors are available to help answer questions about the research study and recommended next steps after an abnormal result. They can be reached at 651-201-3548, seven days a week.
November 19, 2026
At its November 14 meeting in St. Paul, the MMA's Board of Trustees selected six priorities for the upcoming legislative session, which begins January 12, 2027.
November 19, 2026
The Centers for Medicare and Medicaid Services (CMS) announced November 13 that states have the option to pause Medicaid denials and disenrollments due to work requirement non-compliance through June 30, 2027.
November 19, 2026
Minnesota Attorney General Keith Ellison announced on November 16 that his office will not oppose the proposed merger between California-based Sutter Health and Allina Health.